George Goedesky serves as the Vice President of the MALDI Biotyper division at Bruker Daltonics, where he plays a pivotal role in advancing the field of Infectious Disease Diagnostics across the United States and the Americas. With a robust background in sales, marketing, and strategic...
George Goedesky serves as the Vice President of the MALDI Biotyper division at Bruker Daltonics, where he plays a pivotal role in advancing the field of Infectious Disease Diagnostics across the United States and the Americas. With a robust background in sales, marketing, and strategic development within the In Vitro Diagnostics (IVD) industry, George has successfully spearheaded the launch of the Bruker MALDI Biotyper, a groundbreaking technology that enhances microbial identification and characterization. His strategic vision led to the creation of a differentiated value proposition that effectively positions the MALDI Biotyper against entrenched competitors, emphasizing its unique capabilities and clinical value.
George's expertise in value analysis and clinical value analysis has been instrumental in setting up key trial sites that validate the performance of the MALDI Biotyper, ensuring that its benefits are clearly demonstrated to healthcare providers and decision-makers. By aligning and collaborating with key opinion leaders in the microbiology and life sciences sectors, he has fostered a network of advocates who support the adoption of this innovative technology. Furthermore, George has transformed the life science sales group to enhance clinical sales activities, equipping his team with the necessary tools and training to effectively communicate the product's advantages.
His extensive knowledge in molecular biology, clinical research, and value engineering complements his leadership in the pharmaceutical industry, making him a respected figure in the field. Outside of his professional endeavors, George is a dedicated family man, proud of his five children and grandchildren, which adds a personal dimension to his commitment to improving healthcare outcomes through advanced diagnostic solutions.
